Godil Saniya S, Tosi Umberto, Gerges Mina, Garton Andrew L A, Dobri Georgiana A, Kacker Ashutosh, Tabaee Abtin, Anand Vijay K, Schwartz Theodore H
1Department of Neurosurgery, Weill Cornell Medicine, NewYork-Presbyterian Hospital, New York, New York.
2Department of Neurosurgery, Vanderbilt University Medical Center, Nashville, Tennessee.
J Neurosurg. 2021 Oct 15;136(5):1347-1355. doi: 10.3171/2021.5.JNS202011. Print 2022 May 1.
Surgical management of craniopharyngiomas (CPAs) is challenging. Controversy exists regarding the optimal goals of surgery. The purpose of this study was to compare the long-term outcomes of patients who underwent gross-total resection with the outcomes of those who underwent subtotal resection of their CPA via an endoscopic endonasal approach.
From a prospectively maintained database of all endoscopic endonasal approaches performed at Weill Cornell Medicine, only patients with CPAs with > 3 years of follow-up after surgery were included. The primary endpoint was radiographic progression. Data were collected on baseline demographics, imaging, endocrine function, visual function, and extent of resection.
A total of 44 patients with a mean follow-up of 5.7 ± 2.6 years were included. Of these patients, 14 (31.8%) had prior surgery. GTR was achieved in 77.3% (34/44) of all patients and 89.5% (34/38) of patients in whom it was the goal of surgery. Preoperative tumor volume < 10 cm3 was highly predictive of GTR (p < 0.001). Radiation therapy was administered within the first 3 months after surgery in 1 (2.9%) of 34 patients with GTR and 7 (70%) of 10 patients with STR (p < 0.001). The 5-year recurrence-free/progression-free survival rate was 75.0% after GTR and 25.0% after STR (45% in subgroup with STR plus radiotherapy; p < 0.001). The time to recurrence after GTR was 30.2 months versus 13 months after STR (5.8 months in subgroup with STR plus radiotherapy; p < 0.001). Patients with GTR had a lower rate of visual deterioration and higher rate of return to work or school compared with those with STR (p = 0.02). Patients with GTR compared to STR had a lower rate of CSF leakage (0.0% vs 30%, p = 0.001) but a higher rate of diabetes insipidus (85.3% vs 50%, p = 0.02).
GTR, which is possible to achieve in smaller tumors, resulted in improved tumor control, better visual outcome, and better functional recovery but a higher rate of diabetes insipidus compared with STR, even when the latter was supplemented with postoperative radiation therapy. GTR should be the goal of craniopharyngioma surgery, when achievable with minimal morbidity.
颅咽管瘤(CPA)的手术治疗具有挑战性。关于手术的最佳目标存在争议。本研究的目的是比较经鼻内镜入路行CPA全切除患者与次全切除患者的长期预后。
从威尔康奈尔医学院前瞻性维护的所有经鼻内镜手术数据库中,仅纳入术后随访超过3年的CPA患者。主要终点是影像学进展。收集患者的基线人口统计学、影像学、内分泌功能、视觉功能和切除范围等数据。
共纳入44例患者,平均随访5.7±2.6年。其中14例(31.8%)曾接受过手术。所有患者中77.3%(34/44)实现了全切除,以全切除为手术目标的患者中89.5%(34/38)实现了全切除。术前肿瘤体积<10 cm³是全切除的高度预测因素(p<0.001)。34例全切除患者中有1例(2.9%)在术后3个月内接受了放射治疗,10例次全切除患者中有7例(70%)接受了放射治疗(p<0.001)。全切除后的5年无复发/无进展生存率为75.0%,次全切除后为25.0%(次全切除加放疗亚组为45%;p<0.001)。全切除后复发时间为30.2个月,次全切除后为13个月(次全切除加放疗亚组为5.8个月;p<0.001)。与次全切除患者相比,全切除患者视觉恶化率较低,重返工作或学校的比例较高(p = 0.02)。与次全切除患者相比,全切除患者脑脊液漏发生率较低(0.0%对30%,p = 0.001),但尿崩症发生率较高(85.3%对50%,p = 0.02)。
在较小肿瘤中能够实现的全切除,与次全切除相比,即使次全切除后辅以术后放疗,也能改善肿瘤控制、获得更好的视觉预后和功能恢复,但尿崩症发生率较高。当全切除能够以最小的发病率实现时,应将其作为颅咽管瘤手术的目标。